843 related articles for article (PubMed ID: 19095827)
1. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial.
Schramko AA; Suojaranta-Ylinen RT; Kuitunen AH; Kukkonen SI; Niemi TT
Anesth Analg; 2009 Jan; 108(1):30-6. PubMed ID: 19095827
[TBL] [Abstract][Full Text] [Related]
2. Tranexamic acid does not correct the haemostatic impairment caused by hydroxyethyl starch (200 kDa/0.5) after cardiac surgery.
Kuitunen AH; Suojaranta-Ylinen RT; Kukkonen SI; Niemi TT
Blood Coagul Fibrinolysis; 2006 Nov; 17(8):639-45. PubMed ID: 17102650
[TBL] [Abstract][Full Text] [Related]
3. Gelatin and hydroxyethyl starch, but not albumin, impair hemostasis after cardiac surgery.
Niemi TT; Suojaranta-Ylinen RT; Kukkonen SI; Kuitunen AH
Anesth Analg; 2006 Apr; 102(4):998-1006. PubMed ID: 16551888
[TBL] [Abstract][Full Text] [Related]
4. Artificial colloids impair haemostasis. An in vitro study using thromboelastometry coagulation analysis.
Niemi TT; Kuitunen AH
Acta Anaesthesiol Scand; 2005 Mar; 49(3):373-8. PubMed ID: 15752404
[TBL] [Abstract][Full Text] [Related]
5. Profound effects of cardiopulmonary bypass priming solutions on the fibrin part of clot formation: an ex vivo evaluation using rotation thromboelastometry.
Brinkman AC; Romijn JW; van Barneveld LJ; Greuters S; Veerhoek D; Vonk AB; Boer C
J Cardiothorac Vasc Anesth; 2010 Jun; 24(3):422-6. PubMed ID: 20056447
[TBL] [Abstract][Full Text] [Related]
6. Effects of intravascular volume therapy using hydroxyethyl starch (130/0.4) on post-operative bleeding and transfusion requirements in children undergoing cardiac surgery: a randomized clinical trial.
Chong Sung K; Kum Suk P; Mi Ja Y; Kyoung Ok K
Acta Anaesthesiol Scand; 2006 Jan; 50(1):108-11. PubMed ID: 16451158
[TBL] [Abstract][Full Text] [Related]
7. Decreased circulating levels of von Willebrand factor after intravenous administration of a rapidly degradable hydroxyethyl starch (HES 200/0.5/6) in healthy human subjects.
de Jonge E; Levi M; Büller HR; Berends F; Kesecioglu J
Intensive Care Med; 2001 Nov; 27(11):1825-9. PubMed ID: 11810130
[TBL] [Abstract][Full Text] [Related]
8. Effect of the combination of mannitol and ringer acetate or hydroxyethyl starch on whole blood coagulation in vitro.
Lindroos AC; Schramko A; Tanskanen P; Niemi T
J Neurosurg Anesthesiol; 2010 Jan; 22(1):16-20. PubMed ID: 19816205
[TBL] [Abstract][Full Text] [Related]
9. Effects of two different hydroxyethyl starch solutions (HES200/0.5 vs. HES130/0.4) on the expression of platelet membrane glycoprotein.
Chen G; Yan M; Lu QH; Gong M
Acta Anaesthesiol Scand; 2006 Oct; 50(9):1089-94. PubMed ID: 16987338
[TBL] [Abstract][Full Text] [Related]
10. Influence of a new hydroxyethylstarch preparation (HES 130/0.4) on coagulation in cardiac surgical patients.
Haisch G; Boldt J; Krebs C; Suttner S; Lehmann A; Isgro F
J Cardiothorac Vasc Anesth; 2001 Jun; 15(3):316-21. PubMed ID: 11426361
[TBL] [Abstract][Full Text] [Related]
11. Impact of the C2/C6 ratio of high-molecular-weight hydroxyethyl starch on pharmacokinetics and blood coagulation in pigs.
Schramm S; Thyes C; Frascarolo P; Buclin T; Burki M; Fisch A; Burmeister MA; Asmis L; Spahn DR
Anesthesiology; 2007 Sep; 107(3):442-51. PubMed ID: 17721247
[TBL] [Abstract][Full Text] [Related]
12. In cardiac surgery patients does Voluven(R) impair coagulation less than other colloids?
Raja SG; Akhtar S; Shahbaz Y; Masood A
Interact Cardiovasc Thorac Surg; 2011 Jun; 12(6):1022-7. PubMed ID: 21398650
[TBL] [Abstract][Full Text] [Related]
13. A new plasma-adapted hydroxyethyl starch preparation: in vitro coagulation studies.
Boldt J; Mengistu A
J Cardiothorac Vasc Anesth; 2010 Jun; 24(3):394-8. PubMed ID: 20005132
[TBL] [Abstract][Full Text] [Related]
14. Effects of albumin 5% and artificial colloids on clot formation in small infants.
Haas T; Preinreich A; Oswald E; Pajk W; Berger J; Kuehbacher G; Innerhofer P
Anaesthesia; 2007 Oct; 62(10):1000-7. PubMed ID: 17845651
[TBL] [Abstract][Full Text] [Related]
15. Volume therapy with a new hydroxyethyl starch solution in cardiac surgical patients before cardiopulmonary bypass.
Boldt J; Lehmann A; Römpert R; Haisch G; Isgro F
J Cardiothorac Vasc Anesth; 2000 Jun; 14(3):264-8. PubMed ID: 10890478
[TBL] [Abstract][Full Text] [Related]
16. Volume replacement with a balanced hydroxyethyl starch (HES) preparation in cardiac surgery patients.
Boldt J; Mayer J; Brosch C; Lehmann A; Mengistu A
J Cardiothorac Vasc Anesth; 2010 Jun; 24(3):399-407. PubMed ID: 20510247
[TBL] [Abstract][Full Text] [Related]
17. A randomized prospective analysis of alteration of hemostatic function in patients receiving tranexamic acid and hydroxyethyl starch (130/0.4) undergoing off pump coronary artery bypass surgery.
Chakravarthy M; Muniraj G; Patil S; Suryaprakash S; Mitra S; Shivalingappa B
Ann Card Anaesth; 2012; 15(2):105-10. PubMed ID: 22508200
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic effects of 6% and 10% hydroxyethyl starch solutions versus 4% albumin solution in septic patients.
Friedman G; Jankowski S; Shahla M; Gomez J; Vincent JL
J Clin Anesth; 2008 Nov; 20(7):528-33. PubMed ID: 19019650
[TBL] [Abstract][Full Text] [Related]
19. Comparing the effects of 5% albumin and 6% hydroxyethyl starch 130/0.4 on coagulation and inflammatory response when used as priming solutions for cardiopulmonary bypass.
Choi YS; Shim JK; Hong SW; Kim JC; Kwak YL
Minerva Anestesiol; 2010 Aug; 76(8):584-91. PubMed ID: 20661198
[TBL] [Abstract][Full Text] [Related]
20. A prospective randomized study of hydroxyethyl starch, albumin, and lactated Ringer's solution as priming fluid for cardiopulmonary bypass.
Sade RM; Stroud MR; Crawford FA; Kratz JM; Dearing JP; Bartles DM
J Thorac Cardiovasc Surg; 1985 May; 89(5):713-22. PubMed ID: 2581099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
